Discovery of Thermal Sensitizers That Inhibit Heat-Induced SAFB Granule Formation
Journal of Medicinal Chemistry · 12.03.2026 · 69 (5) · 5944-5955
DOI: 10.1021/acs.jmedchem.5c03361 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Medicinal Chemistry, online erschienen am 18.02.2026. Verfasst von Yuji Furutani und 4 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Interdisciplinary Science and Engineering in Health Systems, Okayama University, Okayama 7008530, Japan. Hauptthemen laut MEDLINE: Hyperthermia, Induced, Antineoplastic Agents, Drug Discovery. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Amano Institute of Technology, Japan Agency for Medical Research and Development, Wesco Science Foundation.
Abstract (Originalsprache)
Hyperthermia is a minimally invasive cancer treatment based on heat stress-induced apoptosis. Its therapeutic efficacy, however, is often limited by tumor heterogeneity and acquired thermotolerance. Therefore, combination strategies involving hyperthermia and chemotherapy have been developed to enhance the therapeutic efficacy. Previously, we showed that SB366791 enhanced heat-induced apoptosis by inhibiting heat stress-induced scaffold attachment factor B (SAFB) granule formation, although its proapoptotic activity was insufficient. Therefore, we screened to identify novel compounds that enhance heat-induced apoptosis by suppressing SAFB granule formation. We identified four hit compounds that inhibited SAFB granule formation, all exhibiting thermal enhancement ratios > 1.0─that significantly enhanced heat-induced apoptosis efficiency. Additionally, the tumor volume in mice treated with a combination of Z19024498 and hyperthermia was significantly smaller than that in mice treated with hyperthermia or Z19024498. These results indicate that the identified compounds, specifically Z19024498, have potential as thermal sensitizers for hyperthermia therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Faculty of Interdisciplinary Science and Engineering in Health Systems, Okayama University, Okayama 7008530, Japan.
ORCID-Profile: Takashi Ohtsuki, Kazunori Watanabe
Förderung
- Amano Institute of Technology
- Japan Agency for Medical Research and Development
- Wesco Science Foundation
Zitieren
APA
Furutani, Y., Shimasaki, N., Yamada, R., Ohtsuki, T., & Watanabe, K. (2026). Discovery of Thermal Sensitizers That Inhibit Heat-Induced SAFB Granule Formation. Journal of Medicinal Chemistry, 69(5), 5944-5955. https://doi.org/10.1021/acs.jmedchem.5c03361
Vancouver
Furutani Y, Shimasaki N, Yamada R, Ohtsuki T, Watanabe K. Discovery of Thermal Sensitizers That Inhibit Heat-Induced SAFB Granule Formation. Journal of Medicinal Chemistry. 2026;69(5):5944-5955. doi:10.1021/acs.jmedchem.5c03361
BibTeX
@article{Furutani2026,
author = {Furutani, Yuji and Shimasaki, Natsuki and Yamada, Riko and Ohtsuki, Takashi and Watanabe, Kazunori},
title = {Discovery of Thermal Sensitizers That Inhibit Heat-Induced SAFB Granule Formation},
journal = {Journal of Medicinal Chemistry},
year = {2026},
volume = {69},
number = {5},
pages = {5944--5955},
doi = {10.1021/acs.jmedchem.5c03361}
}
EUVIMED